Overview

Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis

Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the clinical efficacy and safety of dental pulp mesenchymal stem cells in the treatment of primary mild to moderate knee osteoarthritis through a comparative study with sodium hyaluronate. 20 participants will receive low dose of dental pulp mesenchymal stem cells, 20 participants will receive high dose and another 20 participants will receive sodium hyaluronate
Phase:
Early Phase 1
Details
Lead Sponsor:
CAR-T (Shanghai) Biotechnology Co., Ltd.
Treatments:
Hyaluronic Acid